Correlation Analysis Between IFIT2 and HLA Class II in Oral Cancer

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Interferon (IFN)-induced protein with tetratricopeptide repeats 2 (IFIT2) depletion is linked to oral cancer progression.
• Interferon (IFN) can induce human leukocyte antigen (HLA) class II molecules in cancer cells.
• The relationship between IFIT2 and HLA class II in oral cancer is not well understood.

Purpose of the Study:

• To investigate the correlation between IFIT2 and HLA class II expression in oral cancer.
• To determine the role of IFIT2 in oral cancer progression and response to IFN.
• To assess the clinical significance of IFIT2 and HLA class II expression in oral cancer patients.

Main Methods:

• Utilized xenograft and experimental metastasis animal models for in vivo oral cancer progression studies.
• Employed cDNA microarray analysis, Western blotting, and immunohistochemical staining.
• Examined protein and gene expression levels of IFIT2 and HLA class II in oral cancer cells and patient samples.

Main Results:

• Loss of HLA class II expression was associated with IFIT2 depletion in oral cancer models.
• IFIT2 may enhance oral cancer cell responsiveness to IFN-γ-induced HLA class II expression.
• Clinically, IFIT2 protein expression positively correlates with HLA class II expression in oral cancer. Low HLA class II expression is linked to lymph node metastasis.
• Analysis suggests HLA class II expression and CD4+ T cell enrichment predict better prognosis in head and neck cancers.

Conclusions:

• IFIT2 expression is positively correlated with HLA class II expression in oral cancer.
• Low expression of HLA class II molecules may be associated with lymph node metastasis in oral cancer patients.
• IFIT2 may influence oral cancer progression and immune response through HLA class II modulation.